X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (46253) 46253
Book Review (6221) 6221
Publication (2155) 2155
Book Chapter (73) 73
Conference Proceeding (50) 50
Magazine Article (27) 27
Dissertation (9) 9
Web Resource (4) 4
Book / eBook (3) 3
Data Set (3) 3
Presentation (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (43025) 43025
index medicus (41186) 41186
remission induction (36937) 36937
female (27620) 27620
male (27291) 27291
middle aged (21723) 21723
adult (21289) 21289
aged (14810) 14810
treatment outcome (12463) 12463
oncology (10784) 10784
antineoplastic combined chemotherapy protocols - therapeutic use (10357) 10357
adolescent (9257) 9257
hematology (9174) 9174
prognosis (6320) 6320
remission (6221) 6221
follow-up studies (6146) 6146
child (6014) 6014
combined modality therapy (5654) 5654
chemotherapy (5466) 5466
therapy (5387) 5387
retrospective studies (5204) 5204
abridged index medicus (5146) 5146
recurrence (5139) 5139
time factors (5084) 5084
cancer (4185) 4185
aged, 80 and over (4091) 4091
survival rate (4050) 4050
child, preschool (3758) 3758
young adult (3673) 3673
disease-free survival (3587) 3587
care and treatment (3393) 3393
antineoplastic agents - therapeutic use (3117) 3117
transplantation (2953) 2953
drug administration schedule (2888) 2888
prospective studies (2848) 2848
survival analysis (2837) 2837
neoplasm staging (2835) 2835
antineoplastic combined chemotherapy protocols - adverse effects (2639) 2639
risk factors (2623) 2623
gastroenterology & hepatology (2596) 2596
remission induction - methods (2358) 2358
infant (2354) 2354
children (2310) 2310
rheumatology (2309) 2309
cyclophosphamide - administration & dosage (2303) 2303
drug therapy, combination (2298) 2298
surgery (2273) 2273
medicine & public health (2271) 2271
antineoplastic combined chemotherapy protocols - administration & dosage (2193) 2193
survival (2131) 2131
severity of illness index (2071) 2071
immunology (2066) 2066
leukemia (2063) 2063
immunosuppressive agents - therapeutic use (2040) 2040
medicine, general & internal (2013) 2013
pediatrics (2009) 2009
analysis (2003) 2003
patients (1975) 1975
doxorubicin - administration & dosage (1960) 1960
trial (1950) 1950
cytarabine - administration & dosage (1949) 1949
leukemia, myeloid, acute - drug therapy (1931) 1931
disease progression (1913) 1913
vincristine - administration & dosage (1883) 1883
cisplatin - administration & dosage (1850) 1850
acute disease (1822) 1822
disease (1816) 1816
research (1812) 1812
rituximab (1793) 1793
health aspects (1787) 1787
animals (1786) 1786
hematopoietic stem cell transplantation (1725) 1725
relapse (1664) 1664
diagnosis (1622) 1622
etoposide - administration & dosage (1540) 1540
drug therapy (1524) 1524
management (1523) 1523
transplantation, homologous (1522) 1522
antibodies, monoclonal - therapeutic use (1514) 1514
bone marrow transplantation (1514) 1514
precursor cell lymphoblastic leukemia-lymphoma - drug therapy (1496) 1496
acute myelogenous leukemia (1447) 1447
dose-response relationship, drug (1447) 1447
acute myeloid-leukemia (1444) 1444
transplantation, autologous (1398) 1398
efficacy (1386) 1386
cyclophosphamide (1374) 1374
radiotherapy (1364) 1364
prednisone - administration & dosage (1357) 1357
biopsy (1355) 1355
infliximab (1352) 1352
stem cells (1336) 1336
acute myeloid leukemia (1325) 1325
antineoplastic agents - administration & dosage (1318) 1318
salvage therapy (1273) 1273
clinical trials (1264) 1264
methotrexate - administration & dosage (1243) 1243
hematology, oncology and palliative medicine (1236) 1236
bone-marrow-transplantation (1232) 1232
leukemia, myeloid, acute - therapy (1229) 1229
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (38820) 38820
Japanese (2051) 2051
Russian (1459) 1459
Spanish (796) 796
Chinese (723) 723
French (681) 681
German (570) 570
Polish (456) 456
Italian (267) 267
Hungarian (86) 86
Dutch (73) 73
Portuguese (63) 63
Czech (51) 51
Ukrainian (49) 49
Bulgarian (44) 44
Romanian (28) 28
Korean (25) 25
Danish (22) 22
Croatian (18) 18
Serbian (17) 17
Swedish (12) 12
Hebrew (9) 9
Finnish (6) 6
Norwegian (6) 6
Slovak (6) 6
Bosnian (5) 5
Turkish (4) 4
Lithuanian (3) 3
Icelandic (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


American Journal of Hematology, ISSN 0361-8609, 02/2019, Volume 94, Issue 2, pp. 209 - 215
An intensive “5 + 1” regimen, which included bolus high dose cytarabine (HiDAC) at 3 g/m 2 once daily over 3 hours on days 1‐5 and high dose mitoxantrone (HDM)... 
SURVIVAL | INTENSIVE CHEMOTHERAPY | THERAPY | EARLY DEATH | OLDER PATIENTS | RANDOMIZED-TRIAL | TRANSPLANTATION COMORBIDITY INDEX | CYTARABINE | DAUNORUBICIN | HEMATOLOGY | STANDARD | Chemotherapy | Cytarabine | Transplants & implants | Myeloid leukemia | Leukemia | Stem cells | Remission | Mitoxantrone | Acute myeloid leukemia | Age | Geriatrics
Journal Article
2011, ISBN 9783642181726, ix, 365
This book presents management techniques and practices used in induction chemotherapy. It details the pioneering and cutting edge practices employed in... 
drug therapy | administration & dosage | methods | Antineoplastic Agents | Remission Induction | Neoplasms | Infusions, Intra-Arterial | Chemotherapy, Combination | Chemotherapy | Cancer | Medicine & Public Health | General Practice / Family Medicine | Oncology
Book
Annals of internal medicine, ISSN 0003-4819, 01/2015, Volume 162, Issue 1, pp. 18 - 26
Journal Article
by Feagan, Brian G and Sandborn, William J and Gasink, Christopher and Jacobstein, Douglas and Lang, Yinghua and Friedman, Joshua R and Blank, Marion A and Johanns, Jewel and Gao, Long-Long and Miao, Ye and Adedokun, Omoniyi J and Sands, Bruce E and Hanauer, Stephen B and Vermeire, Severine and Targan, Stephan and Ghosh, Subrata and De Villiers, Willem J and Colombel, Jean-Frederic and Tulassay, Zsolt and Seidler, Ursula and Salzberg, Bruce A and Desreumaux, Pierre and Lee, Scott D and Loftus, Edward V and Dieleman, Levinus A and Katz, Seymour and Rutgeerts, Paul and Bampton, P and Chung, A and Connor, S and Debinski, H and Leong, R and Macrae, F and Pavli, P and Sorrentino, D and van den Bogaerde, J and Vogel, W and Vogelsang, H and Louis, E and Mana, F and Zaltman, C and Aumais, G and Bernstein, C and Bressler, B and Dhalla, S and Marshall, J and Panaccione, R and Ropeleski, M and Stehlik, J and Volfova, M and Brynskov, J and Glerup, H and Abitbol-Selinger, V and Allez, M and Beaugerie, L and Bourreille, A and Cadiot, G and Dupas, J and Grimaud, J and Laharie, D and Lerebours, E and Moreau, J and Baumgart, D and Brand, S and Ebert, M and Ehehalt, R and Hasselblatt, P and Howaldt, S and Klaus, J and Krummenerl, P and Kucharzik, T and Lügering, A and Mudter, J and Preiss, J and Schreiber, S and Stallmach, A and Stein, J and Strauch, U and Salamon, A and Patchett, S and Lahat-Zok, A and Rachmilewitz, D and Annese, V and Bossa, F and Guidi, L and Kohn, A and Rocca, R and Ando, A and Ashida, T and Hanai, H and Ishida, T and Ito, H and Matsumoto, T and Motoya, S and Nakamura, S and Sameshima, Y and Suzuki, Y and Watanabe, K and Yamagami, H and Yamamoto, T and ... and UNITI-IM-UNITI Study Grp and UNITI–IM-UNITI Study Group
New England Journal of Medicine, ISSN 0028-4793, 11/2016, Volume 375, Issue 20, pp. 1946 - 1960
Journal Article
Annals of Internal Medicine, ISSN 0003-4819, 05/2009, Volume 150, Issue 10, pp. 670 - W120
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 08/2013, Volume 369, Issue 8, pp. 711 - 721
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 08/2013, Volume 369, Issue 8, pp. 699 - 710
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 08/2013, Volume 369, Issue 5, pp. 417 - 427
This study of ANCA-associated vasculitis compared a single course of rituximab with conventional immunosuppression with cyclophosphamide followed by... 
WEGENERS-GRANULOMATOSIS | MAINTENANCE | MEDICINE, GENERAL & INTERNAL | ANTIBODY-ASSOCIATED VASCULITIS | RENAL VASCULITIS | CYCLOPHOSPHAMIDE | RITUXIMAB | ANTINEUTROPHIL CYTOPLASMIC AUTOANTIBODIES | RANDOMIZED-TRIAL | SYSTEMIC VASCULITIDES | CELL-ACTIVATION | Recurrence | Azathioprine - therapeutic use | Glucocorticoids - therapeutic use | Double-Blind Method | Drug Administration Schedule | Humans | Immunosuppressive Agents - therapeutic use | Antibodies, Monoclonal, Murine-Derived - administration & dosage | Immunologic Factors - administration & dosage | Kaplan-Meier Estimate | B-Lymphocytes | Rituximab | Cyclophosphamide - adverse effects | Remission Induction | Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - drug therapy | Cyclophosphamide - therapeutic use | Immunosuppressive Agents - adverse effects | Immunologic Factors - adverse effects | Drug Therapy, Combination | Antibodies, Monoclonal, Murine-Derived - adverse effects | Azathioprine - adverse effects | Antibodies, Monoclonal, Murine-Derived - therapeutic use | Immunologic Factors - therapeutic use | Immunosuppression | Vasculitis | Drug therapy | Patient outcomes | Disease | Medical treatment | Hypersensitivity | Patients | Immunosuppressive agents | Cyclophosphamide | Infectious diseases | Lymphocytes B | Antineutrophil cytoplasmic antibodies | Remission | Azathioprine | Index Medicus | Abridged Index Medicus
Journal Article